Related Experiment Video
Updated: Jul 5, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.5K
Detecting ferroptosis and immune infiltration profiles in multiple system atrophy using postmortem brain tissue.
Linxi Chen1,2, Lingqun Mao1, Hongsheng Lu2
1Department of Neurology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China.
Frontiers in Neuroscience
|January 15, 2024
Summary
Ferroptosis and immune cell changes, particularly CD8+ T cells and NK cells, are key in multiple system atrophy with cerebellar dysfunction (MSA-C). Targeting these pathways may offer new therapeutic strategies for MSA-C.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Multiple system atrophy (MSA) involves α-synuclein aggregation and neurodegeneration.
- The roles of ferroptosis and immune responses in MSA pathogenesis are increasingly recognized.
- α-synuclein inclusions in oligodendrocytes characterize MSA.
Purpose of the Study:
- To investigate the association between ferroptosis, immune cell infiltration, and multiple system atrophy with cerebellar dysfunction (MSA-C).
- To identify potential diagnostic biomarkers for MSA-C using gene expression data.
Main Methods:
- RNA sequencing data from MSA-C patients and controls were analyzed.
- Weighted gene co-expression network analysis identified MSA-C-related gene modules.
- Machine learning identified ferroptosis-related genes, and CIBERSORT analyzed immune cell composition.
Main Results:
- Six MSA-C-related ferroptosis genes showed diagnostic value (AUC 0.662–0.791).
- MSA-C exhibited significantly higher proportions of CD8+ T cells (P=0.02) and resting NK cells (P=0.011) compared to controls.
- Gene Ontology and KEGG analyses predicted molecular functions related to these pathways.
Conclusions:
- Ferroptosis and T-cell infiltration are implicated as critical pathways in MSA-C development.
- Targeting ferroptosis and T-cell infiltration pathways may represent disease-modifying therapeutic strategies for MSA-C.

